Gilead Sciences Inc. / PARI Pharma GmbH / 2011 Arresto BioSciences / GlaxoSmithKline Inc. / Operations & Emerging Markets Geography Partnerships / Medicines Patent Pool Gilead / Japan Tobacco Inc. / Pfizer Inc. / Company Overview Gilead Sciences Inc. / HIV / Dainippon Sumitomo Pharma Co. Ltd. / Generic Manufacturers / CGI Pharmaceuticals / Pharmasset / Myogen / Rapidscan Pharma Solutions Inc. / Eyetech Inc. / B. Partners / Merck & Co. Inc. / WHO Group / Menarini Group / YM BioSciences / Altera / Triangle Pharmaceuticals / Robin L. Washington / Bristol-Myers Squibb Company / Calistoga Pharmaceuticals / Astellas Pharma Inc. / NeXstar / F. Hoffmann-La Roche Ltd. / CV Therapeutics / PhD / /
Continent
America / Europe / /
Country
Japan / Canada / United Kingdom / China / Saudi Arabia / Belgium / United States / Ireland / /
Currency
USD / / /
Event
FDA Phase / Earnings Announcement / M&A / Business Partnership / /
Facility
International Headquarters / /
IndustryTerm
health services / imaging / treatment of uncomplicated acute illness / treatment of relapsed small lymphocytic lymphoma / healthcare providers / HIV therapies / treatment of life-threatening diseases / therapies for HIV / pharmaceutical / research-based biopharmaceutical / biopharmaceutical / treatment of HIV / drug-specific delivery device / treatment of patients with relapsed chronic lymphocytic leukemia / generic manufacturing partners / /
MedicalCondition
HBV / macular degeneration / connective tissue diseases / leishmaniasis / hepatitis B / pulmonary / angina / hepatitis / HCV genotype / chronic hepatitis B. Partners / cancer / malaria / liver diseases / chronic / HCV / diseases / non-Hodgkin lymphoma / highest disease / AIDS / infection / Pseudomonas / chronic lymphocytic leukemia / AIDS epidemic / hepatitis C / presumed fungal infection / Cryptococcal Meningitis / cystic fibrosis / influenza / HIV infection / CHC / hypertension / influenza infection / disease / uncomplicated acute illness / pain / visceral leishmaniasis / hepatitis B. In / inflammation / chronic hepatitis B / chronic hepatitis C / small lymphocytic lymphoma / /
World Health Organization / European Union / Gilead Foundation / /
Person
John C. Martin / Norbert W. Bischofberger / John F. Milligan / Gregg H. Alton / Katie L. Watson / John McHutchison / Paul R. Carter / / /
Position
Vice President / Corporate and Medical Affairs Asia-Pacific •A / Executive Vice President and Chief Financial Officer / Vice President / Clinical Research / Chief Executive Officer North America •F oster City / Executive Vice President / Research and Development and Chief Scientific Officer / Senior Vice President / Human Resources / President and Chief Operating Officer / Executive Vice President / Chairman and Chief Executive Officer North America •F oster / Vice President / Commercial Operations / /
Gilead Sciences Advancing Therapeutics. Improving Lives. Company Overview Gilead Sciences, Inc. is a research-based biopharmaceutical